211 related articles for article (PubMed ID: 28093087)
1. Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy - a cohort study.
Zahir MN; Shaikh Q; Shabbir-Moosajee M; Jabbar AA
BMC Cancer; 2017 Jan; 17(1):57. PubMed ID: 28093087
[TBL] [Abstract][Full Text] [Related]
2. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
Khorana AA; Dalal M; Lin J; Connolly GC
Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.
Ramos JD; Casey MF; Crabb SJ; Bamias A; Harshman LC; Wong YN; Bellmunt J; De Giorgi U; Ladoire S; Powles T; Pal SK; Niegisch G; Recine F; Alva A; Agarwal N; Necchi A; Vaishampayan UN; Rosenberg JE; Galsky MD; Yu EY;
Cancer Med; 2017 Jan; 6(1):186-194. PubMed ID: 28000388
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer.
Lee YG; Lee E; Kim I; Lee KW; Kim TM; Lee SH; Kim DW; Heo DS
Cancer Res Treat; 2015 Oct; 47(4):670-5. PubMed ID: 25672586
[TBL] [Abstract][Full Text] [Related]
5. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer.
Vergati M; Della-Morte D; Ferroni P; Cereda V; Tosetto L; La Farina F; Guadagni F; Roselli M
Rejuvenation Res; 2013 Jun; 16(3):224-31. PubMed ID: 23521603
[TBL] [Abstract][Full Text] [Related]
7. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Ferrante N; De Tursi M; Iacobelli S; Cuccurullo F; Büller HR; Feragalli B; Porreca E
Thromb Haemost; 2010 Nov; 104(5):1049-54. PubMed ID: 20806119
[TBL] [Abstract][Full Text] [Related]
8. Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy.
Srikanthan A; Tran B; Beausoleil M; Jewett MA; Hamilton RJ; Sturgeon JF; O'Malley M; Anson-Cartwright L; Chung PW; Warde PR; Winquist E; Moore MJ; Amir E; Bedard PL
J Clin Oncol; 2015 Feb; 33(6):582-7. PubMed ID: 25605848
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer.
Guadagni F; Riondino S; Formica V; Del Monte G; Morelli AM; Lucchetti J; Spila A; D'Alessandro R; Della-Morte D; Ferroni P; Roselli M
World J Gastroenterol; 2017 Jul; 23(28):5187-5195. PubMed ID: 28811713
[TBL] [Abstract][Full Text] [Related]
10. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis.
Moore RA; Adel N; Riedel E; Bhutani M; Feldman DR; Tabbara NE; Soff G; Parameswaran R; Hassoun H
J Clin Oncol; 2011 Sep; 29(25):3466-73. PubMed ID: 21810688
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.
Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M
Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799
[TBL] [Abstract][Full Text] [Related]
12. Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer.
Chavan DM; Huang Z; Song K; Parimi LRH; Yang XS; Zhang X; Liu P; Jiang J; Zhang Y; Kong B; Li L
Medicine (Baltimore); 2017 Oct; 96(42):e7935. PubMed ID: 29049188
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis.
Seng S; Liu Z; Chiu SK; Proverbs-Singh T; Sonpavde G; Choueiri TK; Tsao CK; Yu M; Hahn NM; Oh WK; Galsky MD
J Clin Oncol; 2012 Dec; 30(35):4416-26. PubMed ID: 23150697
[TBL] [Abstract][Full Text] [Related]
14. Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy.
Ferroni P; Guadagni F; Laudisi A; Vergati M; Riondino S; Russo A; Davì G; Roselli M
Oncologist; 2014 May; 19(5):562-7. PubMed ID: 24710308
[TBL] [Abstract][Full Text] [Related]
15. Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3).
Tran B; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Fankhauser C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Garcia Del Muro X; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL
Cancer Med; 2020 Jan; 9(1):116-124. PubMed ID: 31715650
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery.
Rollins KE; Peters CJ; Safranek PM; Ford H; Baglin TP; Hardwick RH
Eur J Surg Oncol; 2011 Dec; 37(12):1072-7. PubMed ID: 21925829
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.
Starling N; Rao S; Cunningham D; Iveson T; Nicolson M; Coxon F; Middleton G; Daniel F; Oates J; Norman AR
J Clin Oncol; 2009 Aug; 27(23):3786-93. PubMed ID: 19398575
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
[TBL] [Abstract][Full Text] [Related]
19. Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer.
Du XL; Zhang Y; Hardy D
Cancer Causes Control; 2016 May; 27(5):695-707. PubMed ID: 27059219
[TBL] [Abstract][Full Text] [Related]
20. Risk for Venous Thromboembolic Events in Patients With Advanced Urinary Tract Cancer Treated With First-Line Chemotherapy.
Bamias A; Tzannis K; Dimitriadis I; Tsironis G; Papatheorodidi AM; Tsiara A; Fragkoulis C; Xirokosta A; Barbarousi D; Papadopoulos G; Zakopoulou R; Varkarakis I; Mitsogiannis I; Adamakis I; Alamanis C; Stravodimos K; Papatsoris AG; Dellis AE; Drivalos A; Ntoumas K; Matsouka H; Halvatsiotis P; Raptis A; Gerotziafas GT; Dimopoulos MA
Clin Genitourin Cancer; 2020 Aug; 18(4):e457-e472. PubMed ID: 32007440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
